Short term tolvaptan increases water intake and effectively decreases urinary calcium oxalate, calcium phosphate, and uric acid supersaturations

PURPOSE: Many patients cannot effectively increase water intake and urine volume to prevent urinary stones. Tolvaptan, a V2 receptor antagonist, blocks water reabsorption in the collecting duct and should reduce urinary supersaturation (SS) of stone forming solutes, but this has never been proven. M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Urol
Main Authors: Cheungpasitporn, Wisit, Erickson, Stephen B., Rule, Andrew D., Enders, Felicity, Lieske, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4870116/
https://ncbi.nlm.nih.gov/pubmed/26598423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2015.11.027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados